Product/Composition:- | Capecitabine |
---|---|
Strength:- | 500 mg tablets 150 mg tablets |
Form:- | Tablets |
Reference Brands:- | Xeloda®(EU & US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Capecitabine is an oral chemotherapy used for breast, colorectal, and gastric cancer. Available in 500 mg and 150 mg tablets under the brand Xeloda® in the US and EU.
Capecitabine, marketed as Xeloda®, is an oral chemotherapy agent used in the treatment of breast cancer, colorectal cancer, and gastric cancer. As a prodrug of 5-fluorouracil (5-FU), Capecitabine is administered in 500 mg and 150 mg tablet strengths in both the US and EU markets. Its oral formulation makes it convenient for outpatient therapy and home administration. Manufactured under stringent GMP guidelines, Capecitabine is a crucial product for B2B oncology pharmaceutical companies targeting cancer care centers and oncology specialists. It presents significant opportunities for global distribution and licensing.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications